Association between financial burden and adjuvant hormonal therapy adherence and persistent use for privately insured women aged 18 –64 years in BCBS of Texas

ConclusionsFinancial burdens including both non-AHT medication and AHT-specific out-of-pocket costs were significantly associated with adherence and persistence to the therapy.

Source: Breast Cancer Research and Treatment - February 8, 2018 Category: Cancer & Oncology Source Type: research